Home Cart 0 Sign in  
X

[ CAS No. 102645-33-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 102645-33-0
Chemical Structure| 102645-33-0
Chemical Structure| 102645-33-0
Structure of 102645-33-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 102645-33-0 ]

Related Doc. of [ 102645-33-0 ]

Alternatived Products of [ 102645-33-0 ]

Product Details of [ 102645-33-0 ]

CAS No. :102645-33-0 MDL No. :MFCD06410679
Formula : C6H3Cl2NO Boiling Point : -
Linear Structure Formula :- InChI Key :UIPSRNHDSBVXHY-UHFFFAOYSA-N
M.W : 176.00 Pubchem ID :2762993
Synonyms :

Calculated chemistry of [ 102645-33-0 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 39.64
TPSA : 29.96 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.02 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.47
Log Po/w (XLOGP3) : 1.9
Log Po/w (WLOGP) : 2.2
Log Po/w (MLOGP) : 1.0
Log Po/w (SILICOS-IT) : 2.79
Consensus Log Po/w : 1.87

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.51
Solubility : 0.549 mg/ml ; 0.00312 mol/l
Class : Soluble
Log S (Ali) : -2.15
Solubility : 1.24 mg/ml ; 0.00705 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.2
Solubility : 0.111 mg/ml ; 0.000628 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.59

Safety of [ 102645-33-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 102645-33-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 102645-33-0 ]
  • Downstream synthetic route of [ 102645-33-0 ]

[ 102645-33-0 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 16110-09-1 ]
  • [ 68-12-2 ]
  • [ 102645-33-0 ]
YieldReaction ConditionsOperation in experiment
56%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -78℃; for 0.5 h;
Stage #2: at -78 - 20℃; for 3 h;
2,5-dichloropyridine-4-carbaldehvde A solution of 2,5-dichloropyridine (27.0 g, 180 mmol) in THF (65 mL) was added via cannula to a cooled solution of LDA (100 mL of a 1 .8 M solution, 180 mmol) in THF (80 mL) at -78 °C. The mixture was stirred at -78 °C for 30 mins, then a solution of DMF (21.1 mL, 271 mmol) in THF (25 mL) was added slowly via syringe. The reaction was stirred at -78 °C for 3 hours and was then warmed to R.T. gradually. The solution was poured into a mixture of ice (800 mL) and cone. HCI (150 mL) and stirred for 20 mins before being basified with NaOH (3.0 M) to pH 9-10, and extracted with Et20 (2 x 500 mL). The combined organic layers were dried over MgS04 and concentrated to give the crude product as pale yellow solid. This solid was suspended in n-hexane with trace EtOAc and boiled for 5 mins. The liquors were decanted and stripped to yield a yellow solid which was purified by Biotage flash chromatography (65i, loaded in DCM / EtOAc, eluted with heptane - 20 percent EtOAc / heptane over 8 CV, then holding for 5 CV) to afford the title compound (17.9 g, 56 percent) as a pale yellow solid, 1H NMR (400 MHz, DMSO-d6) δ 7.85 (s, 1 H) 8.76 (s, 1 H) 10.22 (s, 1 H).
Reference: [1] Patent: WO2011/27249, 2011, A2, . Location in patent: Page/Page column 58
[2] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 23, p. 6578 - 6581
[3] Patent: WO2006/50506, 2006, A1, . Location in patent: Page/Page column 132
[4] Patent: WO2005/73232, 2005, A1, . Location in patent: Page/Page column 34
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 102645-33-0 ]

Chlorides

Chemical Structure| 176433-49-1

[ 176433-49-1 ]

2,5-Dichloronicotinaldehyde

Similarity: 0.92

Chemical Structure| 72990-37-5

[ 72990-37-5 ]

3-Chloroisonicotinaldehyde

Similarity: 0.88

Chemical Structure| 1228957-10-5

[ 1228957-10-5 ]

2-Chloroisonicotinaldehyde hydrate(contain dehydrate aldehyde)

Similarity: 0.86

Chemical Structure| 101066-61-9

[ 101066-61-9 ]

2-Chloroisonicotinaldehyde

Similarity: 0.86

Chemical Structure| 88912-26-9

[ 88912-26-9 ]

2,5-Dichloroisonicotinic acid

Similarity: 0.84

Aldehydes

Chemical Structure| 176433-49-1

[ 176433-49-1 ]

2,5-Dichloronicotinaldehyde

Similarity: 0.92

Chemical Structure| 72990-37-5

[ 72990-37-5 ]

3-Chloroisonicotinaldehyde

Similarity: 0.88

Chemical Structure| 1228957-10-5

[ 1228957-10-5 ]

2-Chloroisonicotinaldehyde hydrate(contain dehydrate aldehyde)

Similarity: 0.86

Chemical Structure| 101066-61-9

[ 101066-61-9 ]

2-Chloroisonicotinaldehyde

Similarity: 0.86

Chemical Structure| 790696-96-7

[ 790696-96-7 ]

2-chloro-3-methylisonicotinaldehyde

Similarity: 0.82

Related Parent Nucleus of
[ 102645-33-0 ]

Pyridines

Chemical Structure| 176433-49-1

[ 176433-49-1 ]

2,5-Dichloronicotinaldehyde

Similarity: 0.92

Chemical Structure| 72990-37-5

[ 72990-37-5 ]

3-Chloroisonicotinaldehyde

Similarity: 0.88

Chemical Structure| 1228957-10-5

[ 1228957-10-5 ]

2-Chloroisonicotinaldehyde hydrate(contain dehydrate aldehyde)

Similarity: 0.86

Chemical Structure| 101066-61-9

[ 101066-61-9 ]

2-Chloroisonicotinaldehyde

Similarity: 0.86

Chemical Structure| 88912-26-9

[ 88912-26-9 ]

2,5-Dichloroisonicotinic acid

Similarity: 0.84